Core Points - The share buyback program is set to run from June 2, 2025, to January 30, 2026, with a total buyback amount of up to DKK 1,000 million, limited to a maximum of 1,600,000 shares [1] - The program complies with EU regulations, specifically EU Commission Regulation No. 596/2014 and EU Commission Delegated Regulation No. 2016/1052, which provide a "Safe Harbour" for such transactions [2] - As of the latest report, a total of 657,000 shares have been repurchased, representing 2.59% of the bank's share capital [2] Transaction Summary - Total shares purchased under the buyback program amount to 242,800 shares at an average price of DKK 1,398.41, totaling DKK 339,532,934 [2] - The bank executed a total of 414,200 shares bought back from January 28, 2025, to May 28, 2025, at an average price of DKK 1,207.12, totaling DKK 499,988,706 [2] - The overall total of shares repurchased under the program stands at 657,000 shares at an average price of DKK 1,277.81, amounting to DKK 839,521,640 [2] Detailed Transactions - A detailed breakdown of transactions on specific reporting days shows various volumes and prices, with the highest recorded price being DKK 1,510.69 for 3,600 shares on August 15, 2025 [4][5][6][7][8][9][10] - The transactions were executed primarily on the XCSE exchange, with multiple trades occurring throughout the reporting days [4][5][6][7][8][9][10]

Group 1 - The merger between Golden Ocean Group Limited and CMB.TECH NV is set to be completed on or around 20 August 2025, pending a positive outcome from the Golden Ocean Special General Meeting on 19 August 2025 [1][2] - Golden Ocean will not issue a separate report for Q2 2025, as its results will be included in CMB.TECH's Q2 2025 results [2] - The last day of trading for Golden Ocean shares on OSE and NASDAQ is 19 August 2025, with the first day of trading for the combined company on 20 August 2025 [4] Group 2 - Golden Ocean operates a fleet of 89 vessels with a total capacity of approximately 13.5 million deadweight tonnes, specializing in the transportation of dry bulk cargoes [3] - The merger will result in CMB.TECH Bermuda Ltd. being the surviving entity, with CMB.TECH as the issuer of the merger consideration shares [1][4] - Key dates for the delivery of CMB.TECH shares to former Golden Ocean shareholders include 21 August 2025 for OSE and 20 August 2025 for NYSE [4]

Core Viewpoint - Siili Solutions Plc is undergoing a management change with the departure of CFO Aleksi Kankainen and the appointment of Tuomas Toropainen as the new CFO, effective September 1, 2025. This transition is expected to support the company's growth and AI strategy implementation [1][5]. Management Changes - Aleksi Kankainen, the current CFO, will leave Siili Solutions at the end of August 2025 after contributing significantly to the company's growth and international expansion [1][3]. - Tuomas Toropainen has been appointed as the new CFO, bringing extensive experience from previous roles in international technology companies, including Nordcloud [1][2]. Leadership Insights - CEO Tomi Pienimäki expressed gratitude towards Aleksi Kankainen for his contributions and highlighted the importance of his financial expertise in the company's strategic progress [3]. - Pienimäki also welcomed Tuomas Toropainen, emphasizing his strong international experience in financial leadership and understanding of the technology sector, which are crucial for advancing Siili's AI strategy and growth [5]. Company Overview - Siili Solutions Plc is recognized as a leader in AI-powered digital development, focusing on helping clients achieve growth and competitive advantage through digital transformation. The company operates primarily in Finland, the Netherlands, the United Kingdom, and Germany [6].

Core Points - BW Energy Limited ("BWE") has approved a Long-Term Incentive Program (LTIP) to align employee interests with shareholders [1] - A total of 1,120,000 share options have been awarded under the LTIP for 2025, with nine employees invited to participate [2] - The strike price for the options is set at NOK 41.56, calculated with a 15.75% premium over the average share price [3] - The options have a vesting period of three years and an exercise period of three years, expiring six years after the award date [3] - Following the new awards, BWE will have a total of 6,696,013 outstanding options [4] - Key executives awarded options include CEO Carl K. Arnet (500,000 options) and CFO Brice Morlot (125,000 options) [4][5] Company Overview - BW Energy is a growth exploration and production (E&P) company focusing on proven offshore oil and gas reservoirs through low-risk phased developments [8] - The company has access to existing production facilities, which allows for reduced time to first oil and cash flow with lower investments [8] - BWE's assets include a 73.5% interest in the Dussafu Marine licence offshore Gabon and various interests in fields in Brazil and Namibia, totaling 599 million barrels of oil equivalent in net 2P+2C reserves and resources at the start of 2025 [8]

Core Points - Equinor ASA shares will be traded on the Oslo Stock Exchange excluding the first quarter 2025 cash dividend starting today [1] - The ex-dividend date is set for 18 August 2025 [1] - The announced dividend amount is 0.37 USD [1]

Group 1 - Sampo plc has initiated a share buyback program with a maximum value of EUR 200 million, which commenced on 7 August 2025 [1][2] - On 15 August 2025, Sampo plc acquired a total of 326,043 A shares at an average price of EUR 9.89 per share [1] - Following the transactions, Sampo plc now holds a total of 2,300,244 A shares, representing 0.09% of the total shares outstanding [2] Group 2 - The share buyback program is in compliance with the Market Abuse Regulation (EU) 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 [1] - The authorization for the buyback program was granted during Sampo's Annual General Meeting on 23 April 2025 [1]

Core Insights - Novartis will present data from 19 abstracts related to its cardiovascular portfolio at the 2025 European Society of Cardiology Congress in Madrid from August 29 to September 1, 2025 [2][3] - The company aims to showcase innovative treatments that can significantly improve cardiovascular outcomes, focusing on established treatments like Entresto and Leqvio, as well as pipeline assets such as pelacarsen and abelacimab [3][7] Presentation Highlights - Pelacarsen will be featured in multiple presentations, including its effect on reducing the need for lipoprotein apheresis in patients with elevated lipoprotein(a) and cardiovascular disease [4][5] - Leqvio's impact on patient quality of life will be highlighted in two VictORION studies, along with its efficacy as a cholesterol-lowering monotherapy [5][6] - The PARACHUTE-HF study will evaluate the efficacy and safety of Entresto in treating heart failure with reduced ejection fraction due to chronic Chagas disease [5][6] Research Focus - Novartis is dedicated to addressing significant unmet needs in cardiovascular disease through advanced science and technology, particularly in genetically driven risk factors and common heart conditions [7][10] - The company collaborates with patients, healthcare professionals, and organizations globally to enhance cardiovascular care beyond medication [8][10]

Core Insights - Guigang is enhancing its tourism sector through a series of cultural events and activities, including the 15th Lotus Culture Series, aimed at boosting visitor numbers and revenue [1][5] - The city is recognized for its ecological strengths and is positioning itself as a key eco-tourism destination for the Guangdong-Hong Kong-Macau Greater Bay Area and ASEAN, with significant tourist attractions and a growing brand reputation [2][4] Tourism Growth - In the first half of the year, Guigang welcomed 32.0634 million visitors, generating 30.121 billion yuan in tourism revenue, reflecting year-on-year increases of 12.88% and 13.87% respectively [2] - Events like the "Douyin Football Carnival" and the National Games Basketball Qualifiers have significantly increased visitor engagement, with the football event achieving 1.83 billion exposures and boosting local tourism metrics [3] Cultural and Tourism Development - Guigang is actively pursuing a three-year campaign to enhance its cultural and tourism industry, with 22 new health and cultural tourism projects signed, totaling an investment of 2.401 billion yuan [4] - The integration of AI into cultural tourism is being explored, exemplified by the launch of an AI intelligent interpretation service at Pingnan County Museum [4] Brand Positioning - Guigang is branding itself as a "City of Sports, Capital of Leisure," leveraging events to enhance its reputation and attract more visitors [3] - The city is creating a new cultural and tourism landscape that combines traditional elements with modern experiences, aiming to establish itself as a thriving hub [5]

Group 1 - The net asset value (NAV) of EfTEN United Property Fund units was 11.24 euros at the end of July, reflecting a month-on-month increase of 0.6% [1] - The fund reported a net profit of 166 thousand euros in July and a total of 1.846 million euros in net profit for the first seven months of 2025, compared to 447 thousand euros in the same period last year [1] - If the investment in EfTEN Real Estate Fund AS shares were recorded at book value, the NAV would be 11.33 euros, indicating a 0.8% month-on-month increase [1] Group 2 - The largest profit of 88 thousand euros in July was generated from the investment in EfTEN Real Estate Fund 5, which saw a net asset value increase of 0.7% month-on-month [2] - The growth of EfTEN Real Estate Fund 5 was primarily supported by EfTEN Kristiine OÜ, which owns the Kristiine shopping center, with its equity value rising by 1.2% month-on-month [2] Group 3 - Invego Uus-Järveküla OÜ, where the fund holds an 80% ownership, completed two terraced houses in the third development stage, generating a profit of 52 thousand euros [3] - The fund also earned 38 thousand euros in interest from its investment in Invego Uus-Järveküla OÜ [3] Group 4 - At the beginning of August, Invego Uus-Järveküla OÜ distributed 1.2 million euros to the fund, which included 126 thousand euros in accrued interest and the remainder as principal repayment [4] - The fund plans to distribute the received interest along with funds from EfTEN Real Estate Fund 5 to investors at the beginning of the fourth quarter of 2025 [4]

Core Insights - Valneva SE has received marketing authorization from Health Canada for its single-dose chikungunya vaccine, IXCHIQ, for individuals aged 12 years and older, complementing previous authorizations in Canada and Europe [1][3][10] - The vaccine demonstrates a sustained immune response for 24 months in 97% of participants, indicating its long-term efficacy [2][5] - The approval is significant as chikungunya outbreaks are increasing globally, particularly in endemic regions, highlighting the need for accessible vaccination [3][4][5] Company Overview - Valneva is a specialty vaccine company focused on developing, manufacturing, and commercializing vaccines for infectious diseases, with a strong track record in advancing vaccines from R&D to market [7] - The company currently markets three proprietary travel vaccines and is advancing multiple vaccine candidates, including those for Lyme disease and Zika virus [7] Industry Context - Chikungunya virus is a mosquito-borne disease causing severe joint pain and other debilitating symptoms, with over 3.7 million cases reported in the Americas from 2013 to 2023 [6] - The World Health Organization has identified chikungunya as a major public health issue, exacerbated by climate change and the geographical spread of mosquito vectors [6] - Valneva's partnership with CEPI aims to enhance access to IXCHIQ in low- and middle-income countries, addressing the growing public health threat posed by chikungunya [4][5]